Impetigo: Does Fusidic Acid Boost Povidone-Iodine?

Impetigo, a highly contagious bacterial skin infection, is a common concern, particularly among children. Characterised by red sores that quickly rupture, ooze, and form a yellowish-brown crust, it can be unsightly and uncomfortable. For years, various treatment approaches have been employed, often combining antiseptic washes with topical or oral antibiotics. A key question that has long puzzled clinicians is the exact role and efficacy of these different components when used together. Does adding a powerful topical antibiotic like fusidic acid truly improve outcomes when an antiseptic like povidone-iodine is already in play, or is the antiseptic alone sufficient?

The conventional wisdom surrounding impetigo treatment often suggested a conservative approach for mild cases, relying on disinfection alone. Antiseptics such as povidone-iodine or chlorhexidine were frequently advocated as useful adjuncts to antibiotic treatment. However, the exact contribution of these antiseptics, especially when combined with potent antibiotics, has been a subject of ongoing debate. While immediate antibiotic treatment is generally advised to ensure rapid cure and prevent the spread of infection, the specific combination of treatments has implications for patient compliance, side effects, and the ever-growing concern of antimicrobial resistance.

Investigating the Efficacy: A Landmark Study

To address the question of whether fusidic acid cream genuinely enhances the treatment effect of povidone-iodine, a significant randomised placebo-controlled trial was conducted in general practices across Greater Rotterdam. This study aimed to test the hypothesis that fusidic acid would *not* increase the treatment effect of disinfecting with povidone-iodine alone in children suffering from impetigo. In essence, they wanted to see if the antiseptic wash was enough, or if the antibiotic cream made a crucial difference.

The trial enrolled 184 children, aged 0-12 years, who presented with non-bullous impetigo. Participants were carefully selected, excluding those who were immunocompromised, had extensive lesions (over 5% of total skin surface), deeper skin infections, high fever, or had recently used antibiotics. The rigorous design ensured that the results would be as clear and unbiased as possible. Children were randomly assigned to one of two groups: one receiving 2% fusidic acid cream, and the other a placebo cream. Crucially, both groups also used povidone-iodine shampoo (75 mg/ml) twice daily for gentle washing of the lesions. The study cream was applied three times a day, with a maximum treatment duration of 14 days or until lesions disappeared. Clinical cure and bacterial cure after one week were the primary outcome measures.

Ground-breaking Results: Fusidic Acid's Undeniable Impact

The findings from this study were remarkably clear and firmly rejected the initial hypothesis. After just one week of treatment, a staggering 55% of patients in the fusidic acid group achieved clinical cure, meaning their lesions had completely disappeared or become dry and crust-free. In stark contrast, only 13% of patients in the placebo group showed the same level of improvement. This represents an enormous difference, with an odds ratio of 12.6, indicating that fusidic acid was vastly more effective. The 'number needed to treat' (NNT) was a mere 2.3, meaning that for every 2.3 children treated with fusidic acid (in combination with povidone-iodine), one additional child was cured compared to the placebo group.

Furthermore, the study observed that the mean affected area in the fusidic acid group steadily declined, while in the placebo group, the mean affected area had actually *increased* after one week of treatment. This stark difference underscores the active therapeutic benefit of fusidic acid. From a microbiological perspective, the results were equally compelling: 91% of children in the fusidic acid group achieved bacterial cure after one week, compared to a mere 32% in the placebo group. Interestingly, *Staphylococcus aureus* was identified in 96% of positive cultures, and no strains were found to be resistant to fusidic acid, suggesting its continued effectiveness against the primary causative agent of impetigo.

While the differences in cure rates became smaller after two and four weeks, this was largely attributed to a higher rate of "crossover treatment" in the placebo group. Faced with worsening or unimproving symptoms, more children in the placebo group received additional antibiotic treatment from their general practitioners. This 'rescue' treatment naturally narrowed the gap in long-term outcomes but highlights the initial ineffectiveness of the placebo-plus-povidone-iodine regimen.

Re-evaluating Povidone-Iodine's Standalone Value

One of the most significant implications of this study is the serious question it raises about the value of povidone-iodine as a standalone or primary adjunctive treatment for impetigo. The alarmingly low cure rate of 13% at one week in the placebo group (who were still using povidone-iodine shampoo), coupled with a higher incidence of adverse effects like pain and burning, suggests that povidone-iodine alone is largely ineffective for treating impetigo. The prolonged healing time in the placebo group might explain the increased discomfort reported.

This finding challenges the long-held belief that simple disinfecting measures are sufficient for mild cases of impetigo. While povidone-iodine may have a role in general hygiene or as a very minor adjunct, the study strongly indicates that it cannot replace the need for an effective antibiotic like fusidic acid. Future research may be needed to further clarify the specific role of various antiseptics in impetigo management, but for now, the evidence points towards the critical importance of topical antibiotic treatment.

Understanding Impetigo: Causes and Symptoms

Before delving into current treatment guidelines, it's essential to understand impetigo itself. It is a superficial skin infection most commonly caused by bacteria, primarily Staphylococcus aureus, and sometimes Streptococcus pyogenes (Group A streptococcus). It often affects children, typically appearing on the face, neck, and hands.

• Non-bullous Impetigo: This is the more common form, starting as small red spots that quickly turn into blisters. These blisters burst, leaving golden-brown crusts, often described as looking like 'stuck-on cornflakes'.
• Bullous Impetigo: This type features larger, fluid-filled blisters that are typically clear, then cloudy, before they burst and leave a thin, varnish-like crust. It's less common and can be more serious, especially in babies.

Impetigo is highly contagious and can spread through direct contact with the sores or contaminated items like towels, bedding, or clothing. Good hygiene is paramount to prevent its spread.

Current UK Treatment Guidelines for Impetigo

In the UK, guidelines for treating impetigo emphasise a tailored approach based on the type and extent of the infection, as well as patient-specific factors. The goal is to achieve a quick cure, prevent spread, and minimise the development of antimicrobial resistance.

Initial Treatment Approaches

For localised non-bullous impetigo in individuals who are not systemically unwell or at high risk of complications, the initial recommendations are:

• Hydrogen Peroxide 1% Cream: This can be considered as a first-line treatment. It is applied two or three times a day for 5 days.
• Topical Antibiotics: If hydrogen peroxide 1% cream is unsuitable (e.g., impetigo around the eyes) or ineffective, a short course of a topical antibiotic is recommended. The first choice is fusidic acid 2% cream, applied three times a day for 5 days. If fusidic acid resistance is suspected or confirmed, mupirocin 2% cream is an alternative, also applied three times a day for 5 days.

For widespread non-bullous impetigo in individuals who are not systemically unwell or at high risk of complications, a short course of either a topical or oral antibiotic can be offered. The choice should consider patient preferences, practicality of administration (especially for large areas), and potential adverse effects. Both topical and oral antibiotics are considered effective in these cases.

Important Note: Combination treatment with a topical and oral antibiotic simultaneously is generally *not* recommended for treating impetigo.

When Oral Antibiotics Are Necessary

Oral antibiotics are advised for specific situations:

• People with non-bullous impetigo who are systemically unwell (e.g., fever, general malaise) or at high risk of complications.
• When topical treatments have failed or the infection is worsening despite appropriate topical application.

The choice of oral antibiotic depends on factors like patient age, allergies, and local antimicrobial resistance data. Flucloxacillin is typically the first-choice oral antibiotic. Alternatives for penicillin allergy or if flucloxacillin is unsuitable include clarithromycin or erythromycin (especially in pregnancy).

Key Treatment Options at a Glance (UK Guidelines)

It's vital to consult a healthcare professional for diagnosis and specific treatment plans, as dosages and suitability vary.

Table 1: Antimicrobials for Adults (18 years and over)

Table 2: Antimicrobials for Children and Young People (under 18 years)

Managing Treatment Challenges and Recurrence

It's crucial to reassess impetigo if symptoms worsen rapidly or significantly at any time, or if they haven't improved after completing a course of treatment. Patients and carers should be advised to seek medical help in such scenarios.

• After Hydrogen Peroxide 1% Cream: If impetigo worsens or hasn't improved, offer a short course of a topical antibiotic (if localised) or a short course of a topical or oral antibiotic (if widespread).
• After Topical Antibiotics: If symptoms worsen or haven't improved, offer a short course of an oral antibiotic.
• After Oral Antibiotics: If symptoms worsen or haven't improved, consider sending a skin swab for microbiological testing. The antibiotic choice should then be reviewed and changed according to results, ideally using a narrow-spectrum antibiotic.
• Recurrent Impetigo: For individuals experiencing frequent impetigo recurrences, consider taking a nasal swab and initiating treatment for decolonisation, as the nose can be a reservoir for *Staphylococcus aureus*.

When to Seek Specialist Advice

Referral or seeking specialist advice for impetigo is important in certain situations:

• Individuals at high risk of complications.
• Those with bullous impetigo, particularly babies aged 1 year and under.
• People with widespread impetigo who are immunocompromised.
• Anyone with impetigo showing symptoms or signs suggesting a more serious illness or condition, such as cellulitis (a deeper skin infection).

Essential Hygiene Measures

Regardless of the treatment approach, advising on good hygiene measures is fundamental to reduce the spread of impetigo to other areas of the body and to other people. This includes:

• Regular hand washing with soap and water.
• Avoiding touching or scratching the sores.
• Keeping nails short.
• Using separate towels, flannels, and bedding for the affected person.
• Washing contaminated items at a high temperature.
• Avoiding close contact with others, especially newborns or those with weakened immune systems, until the sores are crusted over or after 48 hours of antibiotic treatment.

Frequently Asked Questions (FAQs)

What exactly is impetigo?

Impetigo is a very common, highly contagious bacterial skin infection. It typically presents as red sores, often around the nose and mouth, which quickly burst and form characteristic honey-coloured crusts. It's most common in children but can affect anyone.

Is impetigo always caused by the same bacteria?

Most cases of impetigo are caused by *Staphylococcus aureus*. Less commonly, it can be caused by *Streptococcus pyogenes*. The study discussed in this article found *Staphylococcus aureus* in 96% of positive cultures at baseline.

How long does impetigo treatment usually take to work?

With effective treatment, such as topical fusidic acid cream or oral antibiotics, you should see improvement within a few days. The study showed a significant clinical cure rate of 55% after just one week with fusidic acid. A typical course of treatment lasts 5 to 7 days.

Can impetigo come back after treatment?

Yes, impetigo can recur. If it happens frequently, it might be due to persistent bacteria in the nose (nasal carriage of *Staphylococcus aureus*). In such cases, your GP might recommend a nasal swab and decolonisation treatment to eliminate the bacteria from the nasal passages, which can act as a reservoir for infection.

What should I do if the impetigo isn't getting better with treatment?

If your impetigo symptoms worsen rapidly or significantly, or if they haven't improved after completing a course of treatment, you should contact your GP. They may need to reassess the diagnosis, consider alternative treatments, or send a swab for microbiological testing to identify the specific bacteria and its antibiotic sensitivities.

Can I go to work or school with impetigo?

Children should usually stay home from school or nursery until their sores are dry and crusted over, or until they have been on antibiotic treatment for at least 48 hours. Adults should also consider staying home from work if their job involves close contact with others, particularly vulnerable individuals. Good hygiene is crucial to prevent spread.

Conclusion

The evidence is clear: while povidone-iodine has a role as an antiseptic, its effectiveness as a sole or primary adjunctive treatment for impetigo is highly questionable. The landmark study firmly established that fusidic acid cream, when combined with povidone-iodine, is dramatically more effective than povidone-iodine with a placebo. This underscores the critical importance of effective topical antibiotic treatment in managing impetigo.

For anyone dealing with impetigo, understanding and following current UK guidelines is paramount. Whether it's the initial consideration of hydrogen peroxide cream, the targeted use of fusidic acid, or the necessity of oral antibiotics for more severe cases, a well-informed approach ensures effective treatment and helps combat the spread of this common skin infection. Always consult a healthcare professional for a proper diagnosis and the most appropriate treatment plan tailored to your specific situation.

If you want to read more articles similar to Impetigo: Does Fusidic Acid Boost Povidone-Iodine?, you can visit the Automotive category.